Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Edding Genor's GB268 Wins NMPA IND Approval for Phase II Trial – PD‑1/CTLA‑4/VEGF Trispecific Antibody Plus Chemotherapy Targets First‑Line Advanced Colorectal Cancer
CompanyDrug

Edding Genor’s GB268 Wins NMPA IND Approval for Phase II Trial – PD‑1/CTLA‑4/VEGF Trispecific Antibody Plus Chemotherapy Targets First‑Line Advanced Colorectal Cancer

Edding Genor (HKG: 6998) announced that China's National Medical Products Administration (NMPA) has approved its Investigational New Drug (IND) application for a Phase II clinical trial of GB268 — a…

Sichuan Biokin's Iza‑Bren Combination Therapy Clinical Trial Application Approved by NMPA – EGFR×HER3 Bispecific ADC Advances with Radiotherapy in Locally Advanced Unresectable HNSCC

Sichuan Biokin’s Iza‑Bren Combination Therapy Clinical Trial Application Approved by NMPA – EGFR×HER3 Bispecific ADC Advances with Radiotherapy in Locally Advanced Unresectable HNSCC

Transcenta Granted Chinese Invention Patent for Anti‑CLDN18.2 Antibodies – Protecting the Companion Diagnostic for Osemitamab (TST001) in Gastric Cancer

Transcenta Granted Chinese Invention Patent for Anti‑CLDN18.2 Antibodies – Protecting the Companion Diagnostic for Osemitamab (TST001) in Gastric Cancer

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Boehringer Ingelheim Gets NMPA Approval for Phase II Study of BI 764532 in SCLC

CompanyDrug

HanchorBio’s HCB101 Receives WFDA Approval for Multi-Region Clinical Study

CompanyDrug

InnoCare Pharma’s ICP-723 Receives NMPA Approval for Pediatric Clinical Study

CompanyDrug

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group Get NMPA Approval for Solid Tumor Treatment

CompanyDrug

CanSino Biologics Granted Approval by Health Canada for Zoster Vaccine Candidate CS-2032

CompanyDrug

Jiangsu Simcere Pharmaceutical Gets NMPA Approval for Quviviq, Anti-Insomnia Drug

CompanyDrug

Merck and Telix Pharmaceuticals Initiate Phase I Study for CAIX-Expressing Tumors Therapy

CompanyDrug

Chongqing Zhifei Biological Launches Phase I Clinical Trial for Group B Meningococcal Vaccine

Show More